|Bid||3.2300 x 3100|
|Ask||3.2500 x 4000|
|Day's Range||3.1600 - 3.3850|
|52 Week Range||0.7800 - 5.9800|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Performance at Infinity Pharmaceuticals, Inc. ( NASDAQ:INFI ) has been reasonably good and CEO Adelene Perkins has done...
We can readily understand why investors are attracted to unprofitable companies. By way of example, Infinity...
Infinity (INFI) delivered earnings and revenue surprises of -7.14% and 0.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?